Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1991-10-7
pubmed:abstractText
1. Although (+)-tubocurarine (Tc) is classically considered to be a competitive antagonist at the neuromuscular junction, kinetic details of the interaction remain unclear. 2. We studied the competitive action of Tc on the nicotinic receptor at the frog neuromuscular junction using a quantitative analysis of the generation phase of miniature endplate currents (m.e.p.cs) recorded in Ringer solution (20 degrees C) under voltage clamp (-90 mV) in the absence or presence of 1-5 microM Tc. Under control conditions four neurotransmission parameters were estimated by non-linear regression using a mathematical model of synaptic transmission incorporating transmitter release, diffusion, hydrolysis, receptor binding and channel gating. These parameters were then used in a further regression to estimate binding rate constants for Tc at the same endplate. Allowance was made for open channel block by Tc, which under the conditions of this study was only a small component of total blockade. 3. The results suggest that Tc binds to the two agonist recognition sites on the nicotinic receptor with equal affinity (stoichiometric KDs of 2.2 and 8.8 microM), and that most of the functional blockade at concentrations up to 5 microM is due to occupancy of only one site. 4. The association rate constant for Tc binding to sites on the nicotinic acetylcholine receptor appears to be very fast (k+D = 8.9 x 10(8) M-1 s-1) and comparable to that for acetylcholine (ACh). 5. In the brief time during which an m.e.p.c. is generated (approximately 200 microseconds, reversal of Tc blockade by transiently high concentrations of ACh seems to be kinetically limited.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-14407080, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-1968348, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-2146385, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-2172443, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-2306494, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-2311657, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-2416403, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-2423117, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-2457689, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-2461364, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-262376, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-2642001, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-2706266, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-2713760, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-2720078, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-2844556, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-2907694, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-3030499, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-315462, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-3270966, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-3771559, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-3790698, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-3916127, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-4045419, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-4545375, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-470928, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-4871939, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-518850, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-6089060, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-6254051, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-6260951, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-6330348, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-6584895, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-6607088, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-678518, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-6885779, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-6885781, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-6932045, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-6947281, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-6978750, http://linkedlifedata.com/resource/pubmed/commentcorrection/1884116-7240238
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
103
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1607-13
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1991
pubmed:articleTitle
Kinetics of (+)-tubocurarine blockade at the neuromuscular junction.
pubmed:affiliation
Department of Pharmacology, University of Western Australia.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't